PSYENCE BIOMEDICAL LTD (PBMWW) Top Institutional Shareholders
PSYENCE BIOMEDICAL LTD (PBMWW) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $94,558 in PBMWW holdings during the latest filing period.
Harraden Circle Investments, Llc is currently the largest disclosed institutional shareholder of PBMWW tracked by InsiderSet, reporting ownership valued at approximately $20,929 in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $34,155, representing an estimated gain of +63.19% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 89% of the total disclosed PBMWW value among the investors covered in this analysis. Major shareholders include Harraden Circle Investments, Llc, Polar Asset Management Partners Inc., Mmcap International Inc. Spc, and several other long-term asset managers with concentrated positions in PSYENCE BIOMEDICAL LTD (PBMWW).
This page ranks the largest institutional PBMWW shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
18
Total Reported Value
$94,558
Largest Holder
Harraden Circle Investments, Llc
Largest Position
$20,929
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
21
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Harraden Circle Investments, Llc | 0.00% | 1,150,000 | $20,929 | $34,155 | +$13,226 | +63.19% | |
| Polar Asset Management Partners Inc. | 0.00% | 733,000 | $13,341 | $21,770 | +$8,429 | +63.18% | |
| Mmcap International Inc. Spc | 0.00% | 600,000 | $10,920 | $17,820 | +$6,900 | +63.19% | |
| Toronto Dominion Bank | 0.00% | 503,312 | $9,060 | $14,948 | +$5,888 | +64.99% | |
| Calamos Advisors Llc | 0.00% | 500,000 | $9,050 | $14,850 | +$5,800 | +64.09% | |
| Saba Capital Management, L.P. | 0.00% | 297,847 | $5,406 | $8,846 | +$3,440 | +63.63% | |
| Clear Street Group Inc. | 0.00% | 257,209 | $4,681 | $7,639 | +$2,958 | +63.19% | |
| Aristeia Capital, L.L.C. | 0.00% | 215,319 | $3,908 | $6,395 | +$2,487 | +63.64% | |
| Goldman Sachs Group Inc | 0.00% | 200,117 | $3,642 | $5,943 | +$2,301 | +63.19% | |
| Lmr Partners Llp | 0.00% | 200,000 | $3,640 | $5,940 | +$2,300 | +63.19% | |
| D. E. Shaw & Co., Inc. | 0.00% | 175,352 | $3,174 | $5,208 | +$2,034 | +64.08% | |
| Tenor Capital Management Co., L.P. | 0.00% | 150,000 | $2,730 | $4,455 | +$1,725 | +63.19% | |
| Wolverine Asset Management Llc | 0.00% | 147,101 | $2,677 | $4,369 | +$1,692 | +63.20% | |
| Lpl Financial Llc | 0.00% | 49,095 | $894 | $1,458 | +$564 | +63.10% | |
| Parallel Advisors, Llc | 0.00% | 27,500 | $500 | $817 | +$317 | +63.35% | |
| Ubs Group Ag | 0.00% | 247 | $4 | $7 | +$3 | +83.40% | |
| Mint Tower Capital Management B.V. | 0.00% | 50,000 | $1 | $1,485 | +$1,484 | +148400.00% | |
| Virtu Financial Llc | 0.00% | 27,853 | $1 | $827 | +$826 | +82623.41% |
Frequently asked questions about PBMWW
Who owns the most PBMWW stock?
The largest holders of PBMWW are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for PSYENCE BIOMEDICAL LTD (PBMWW).
Is PBMWW widely held by superinvestors?
Many widely followed stocks like PBMWW appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly PBMWW is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.